Table 5 Factors associated with acetate acid derivate consumption: odds ratios and 95% confidence intervals adjusted for the remaining factors in the table and province of recruitment
From: Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study
Variable | Category | Ever consumption | Current consumption | ||
|---|---|---|---|---|---|
Women | Men | Women | Men | ||
Age | < 45 | 1.12 (0.51–2.43) | 0.76 (0.22–2.59) | 0.86 (0.26–2.81) | 2.88 (0.39–21.2) |
45–54 | 1.00 (ref) | 1 (ref) | 1 (ref) | 1 (ref) | |
55–64 | 0.86 (0.47–1.55) | 0.58 (0.28–1.19) | 0.73 (0.29–1.84) | 1.44 (0.33–6.27) | |
65–74 | 0.66 (0.34–1.26) | 0.52 (0.26–1.06) | 0.52 (0.18–1.45) | 0.96 (0.22–4.19) | |
≥75 | 0.81 (0.39–1.68) | 0.48 (0.22–1.06) | 0.73 (0.24–2.24) | 1.20 (0.25–5.62) | |
BMI | < 18.5 | 0.27 (0.03–2.13) | 2.62 (0.17–40.8) | 0.78 (0.09–6.66) | – |
18.5–24.9 | 1.00 (ref) | 1 (ref) | 1 (ref) | 1 (ref) | |
25–29.9 | 1.30 (0.84–2.00) | 1.22 (0.76–1.97) | 1.67 (0.87–3.22) | 0.49 (0.22–1.06) | |
≥30 | 1.57 (0.97–2.56) | 1.32 (0.74–2.34) | 1.27 (0.57–2.83) | 0.81 (0.34–1.94) | |
Education | Less than primary | 1 (ref) | 1 (ref) | 1 (ref) | 1 (ref) |
Primary education | 1.14 (0.67–1.96) | 1.34 (0.70–2.57) | 0.69 (0.30–1.58) | 1.45 (0.46–4.57) | |
Secondary education | 0.86 (0.46–1.59) | 2.27 (1.20–4.28) | 0.58 (0.23–1.50) | 1.93 (0.63–5.89) | |
University | 1.41 (0.73–2.71) | 2.15 (1.09–4.27) | 1.29 (0.49–3.35) | 2.40 (0.73–7.87) | |
No. of births | (by each birth) | 0.97 (0.85–1.10) | 1.12 (0.94–1.33) | – | |
Premenopause (ref.: postmenopause) | 0.45 (0.23–0.86) | 0.58 (0.22–1.49) | – | ||
Smoking | No smoker | 1 (ref) | 1 (ref) | 1 (ref) | 1 (ref) |
Former smoker | 1.20 (0.73–1.99) | 0.91 (0.57–1.44) | 0.94 (0.42–2.08) | 1.66 (0.71–3.84) | |
Current smoker | 1.72 (1.03–1.99) | 0.91 (0.51–1.63) | 1.33 (0.59–2.99) | 0.96 (0.31–3.02) | |
Alcohol consumption at recruitment (g/day) | |||||
Abstainers | 1 (ref) | 1 (ref) | 1 (ref) | 1 (ref) | |
0–39.9 (men), 0–19.9 (women) | 0.90 (0.55–1.48) | 1.14 (0.59–2.19) | 1.01 (0.46–2.21) | 0.88 (0.27–2.81) | |
40–59.9 (men), 20–39.9 (women) | 1.27 (0.50–3.24) | 1.98 (0.83–4.73) | 0.85 (0.19–3.81) | 1.28 (0.27–6.08) | |
≥ 60 g/day (men), ≥40 g/day (women) | 1.80 (0.26–12.3) | 1.40 (0.46–4.31) | 3.43 (0.18–64.1) | 2.80 (0.50–15.6) | |
Alcohol when 30–40 years old | |||||
Abstainers | 1 (ref) | 1 (ref) | 1 (ref) | 1 (ref) | |
0–39.9 (men), 0–19.9 (women) | 1.24 (0.75–2.04) | 0.75 (0.39–1.41) | 1.35 (0.61–2.97) | 7.92 (0.95–66.0) | |
40–59.9 (men), 20–39.9 (women) | 2.23 (0.95–5.22) | 1.08 (0.49–2.37) | 4.28 (1.27–14.5) | 7.98 (0.84–76.2) | |
≥ 60 g/day (men), ≥40 g/day (women) | 1.35 (0.36–5.08) | 0.87 (0.40–1.89) | – | 3.32 (0.32–34.6) | |
Chronic disease involving pain | |||||
Yes (ref: No) | 2.69 (1.81–4.00) | 3.49 (2.33–5.21) | 3.23 (1.72–6.06) | 4.28 (2.10–8.71) | |